BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 19324446)

  • 1. Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis.
    Boelens MC; Kok K; van der Vlies P; van der Vries G; Sietsma H; Timens W; Postma DS; Groen HJ; van den Berg A
    Lung Cancer; 2009 Dec; 66(3):372-8. PubMed ID: 19324446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genomic changes in primary lesion and lymph node metastases of esophageal squamous cell carcinoma].
    Qin YR; Wang LD; Dora K; Guan XY; Zhuang ZH; Fan ZM; Deng W; Cao SH
    Ai Zheng; 2005 Sep; 24(9):1048-53. PubMed ID: 16159423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonrandom DNA copy number changes related to lymph node metastases in squamous cell carcinoma of the lung.
    Rydzanicz M; Giefing M; Ziolkowski A; Kasprzyk M; Gabriel A; Dyszkiewicz W; Szyfter K
    Neoplasma; 2008; 55(6):493-500. PubMed ID: 18999877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chromosomal imbalance in primary lung squamous cell carcinoma and their relationship with smoking].
    Yan WS; Song LY; Wei WD; Li A; Liang QW; Liu JH; Fang Y
    Ai Zheng; 2005 Jan; 24(1):47-52. PubMed ID: 15642199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal aberrations of malignant pleural effusions of lung adenocarcinoma: different cytogenetic changes are correlated with genders and smoking habits.
    Yen CC; Liang SC; Jong YJ; Chen YJ; Lin CH; Chen YM; Wu YC; Su WC; Huang CY; Tseng SW; Whang-Peng J
    Lung Cancer; 2007 Sep; 57(3):292-301. PubMed ID: 17553591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung.
    Petersen S; Aninat-Meyer M; Schlüns K; Gellert K; Dietel M; Petersen I
    Br J Cancer; 2000 Jan; 82(1):65-73. PubMed ID: 10638968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas.
    Speicher MR; Howe C; Crotty P; du Manoir S; Costa J; Ward DC
    Cancer Res; 1995 Mar; 55(5):1010-3. PubMed ID: 7866983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of chromosomal aberrations between primary tumors and their synchronous lymph-node metastases in intestinal-type gastric carcinoma.
    Liu XP; Li DY; Liu XL; Xu JD; Furuya T; Kawauchi S; Oga A; Sasaki K
    Pathol Res Pract; 2009; 205(2):105-11. PubMed ID: 19041191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative genomic hybridization array analysis and real time PCR reveals genomic alterations in squamous cell carcinomas of the lung.
    Choi YW; Choi JS; Zheng LT; Lim YJ; Yoon HK; Kim YH; Wang YP; Lim Y
    Lung Cancer; 2007 Jan; 55(1):43-51. PubMed ID: 17109992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
    Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
    Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung.
    O-charoenrat P; Rusch V; Talbot SG; Sarkaria I; Viale A; Socci N; Ngai I; Rao P; Singh B
    Clin Cancer Res; 2004 Sep; 10(17):5792-803. PubMed ID: 15355908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypic analysis of esophageal squamous cell carcinoma by molecular cytogenetics and real-time quantitative polymerase chain reaction.
    Yen CC; Chen YJ; Lu KH; Hsia JY; Chen JT; Hu CP; Chen PM; Liu JH; Chiou TJ; Wang WS; Yang MH; Chao TC; Lin CH
    Int J Oncol; 2003 Oct; 23(4):871-81. PubMed ID: 12963965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal aberrations in squamous cell carcinoma and solar keratoses revealed by comparative genomic hybridization.
    Ashton KJ; Weinstein SR; Maguire DJ; Griffiths LR
    Arch Dermatol; 2003 Jul; 139(7):876-82. PubMed ID: 12873882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of molecular events in squamous and non-squamous cell lung carcinoma.
    Yakut T; Schulten HJ; Demir A; Frank D; Danner B; Egeli U; Gebitekin C; Kahler E; Gunawan B; Urer N; Oztürk H; Füzesi L
    Lung Cancer; 2006 Dec; 54(3):293-301. PubMed ID: 17011066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic aberrations in carcinomas of the uterine corpus.
    Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of regional and distant metastasis in patients with eyelid and periocular squamous cell carcinoma.
    Faustina M; Diba R; Ahmadi MA; Esmaeli B
    Ophthalmology; 2004 Oct; 111(10):1930-2. PubMed ID: 15465559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative genomic hybridization of bronchial carcinomas and their metastases].
    Petersen I; Petersen S; Bockmühl U; Schwendel A; Wolf G; Dietel M
    Verh Dtsch Ges Pathol; 1997; 81():297-305. PubMed ID: 9474883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Deletion of chromosome 10q--a marker for metastasis of head-neck carcinomas?].
    Bockmühl U; Schmidt S; Petersen S; Petersen I
    Laryngorhinootologie; 2000 Feb; 79(2):81-5. PubMed ID: 10738714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
    Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
    Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.